The Indian Pharma industry has generated astounding growth in the past decades fuelled by increasing burden of disease. In order for the Indian pharmaceutical industry to maximize its true potential, ideation, innovation and integration are pre-requisites to reaching this stupendous growth. The numerous innovations leading to discovery of new life-saving drugs are through intellectual property rights (IPRs). IPR is a requirement for pharma companies for identification, planning, commercialization and protection of invention. The intellectual property market has manifested growth at an unprecedented pace. Risks abound and rights holders need strategic knowledge to maximize their success in the jurisdiction. The Patent Act, 1970 has played a significant role in taking India to the global patent arena.
With this overarching global theme of Ideate and Innovate, CPhI Conferences is pleased to present the, '8th Annual Pharma IPR Conference' scheduled on 6th - 8th March 2019 in Mumbai.
Driven by powerful content and unmatched speaker profiles, the forum promises to provide an exceptional opportunity to bring all key stakeholders, IP Attorneys and Counsels from across the globe on a single platform to discuss, deliberate and share their thoughts on achieving the next phase of growth, recent trends and best practices in the Pharma IPR space!
Partner, Patent Attorney
Dr. Alpesh Pathak
Global IP Head
Intas Pharmaceuticals Ltd.
Anshul Sunil Saurastri
Krishna & Saurastri Associates LLP.
Dr. Bharati Nadkarni
HEAD - IPM & Patent Counsel
Unichem Laboratories Limited
Regional Vice President - National Accounts
Xact Data Discovery
Head of Law and Partner
Nichole M Valeyko
Dr. Paras Vasanani
Assistant General Manager – Global Intellectual Property Department
Amneal Pharmaceuticals Pvt Ltd.
Dr. Poonam Raghuvanshi
Vice President & Head – Intellectual Property
Dr. Reddy’s Laboratories
Head- Pharmaceuticals and Life Sciences
Steven M. Coyle
Partner and Litigation Department Co-Chair
Cantor Colburn LLP
Taranpreet Singh Lamba
Vice President of Intellectual Property and Global Product Portfolio Management
Glenmark Pharmaceuticals Ltd.
Vice President – National Accounts
Xact Data Discovery
Tedd Van Buskirk